Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa

Alimentary Pharmacology and Therapeutics

Volumn 44, Issue 10, 2016, Pages 1005-1017

  Keane, E ^a,b   Funk, A L ^c   Shimakawa, Y ^c  

^a Bioinformatique et Chimie Moléculaire   (France)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

AFRICA SOUTH OF THE SAHARA; ANTIVIRAL THERAPY; ASIA; COHORT ANALYSIS; GEOGRAPHIC DISTRIBUTION; HEMAGGLUTINATION TEST; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFANT DISEASE; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; MATERNAL BLOOD; MATERNAL TREATMENT; MOTHER TO CHILD TRANSMISSION; PERINATAL INFECTION; PERINATAL PERIOD; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW; VIRUS TRANSMISSION; BLOOD; FEMALE; META ANALYSIS; MOTHER; PREGNANCY; PREGNANCY COMPLICATION; RISK; TRANSMISSION; VERTICAL TRANSMISSION; VIROLOGY;

AFRICA SOUTH OF THE SAHARA; FEMALE; HEPATITIS B; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MOTHERS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK;

EID: 84987755507     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13795     Document Type: Review

References (56)

1. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015; 6736: 1–10.
2. Cowie BC, MacLachlan JH. The global burden of liver disease attributable to hepatitis B, hepatitis C, and alcohol: increasing mortality, differing causes. Hepatology 2013; 58: 218A–9A.
3. Kiire CF. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. Gut 1996; 38(suppl. 2): S5–12.
4. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28: 112–25.
5. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995; 20: 992–1000.
6. Chang M-H. Natural history and clinical management of chronic hepatitis B virus infection in children. Hepatol Int 2008; 2(suppl. 1): S28–36.
7. Shimakawa Y, Yan H-J, Tsuchiya N, Bottomley C, Hall AJ. Association of early age at establishment of chronic hepatitis B infection with persistent viral replication, liver cirrhosis and hepatocellular carcinoma: a systematic review. PLoS ONE 2013; 8: e69430.
8. Shimakawa Y, Lemoine M, Bottomley C, et al. Birth order and risk of hepatocellular carcinoma in chronic carriers of hepatitis B virus: a case-control study in The Gambia. Liver Int 2015; 35: 2318–26.
9. Shimakawa Y, Lemoine M, Njai HF, et al. Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia. Gut 2015; doi:10.1136/gutjnl-2015-309892 [Epub ahead of print].
10. WHO. Combating Hepatitis B and C to Reach Elimination by 2030. Geneva, Switzerland: WHO, 2016.
11. Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005; 16: 1–31.
12. WHO. Preventing Mother-to-child Transmission of Hepatitis B: Operational Field Guidelines for Delivery of the Birth Dose of Hepatitis B Vaccine. Geneva, Switzerland: WHO, 2006.
13. Visvanathan K, Dusheiko G, Giles M, et al. Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut 2016; 65: 340–50.
14. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y, Mayumi M. E antigen and anti-E in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976; 294: 746–9.
15. Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977; 105: 94–8.
16. Stevens CE, Neurath RA, Beasley RP, Szmuness W. HBeAg and anti-hbe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol 1979; 3: 237–41.
17. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62: e1–34.
18. Weinbaum CM, Williams I, Mast EE, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008; 8: 1–20.
19. Altman DG. Systematic reviews of evaluations of prognostic variables. In: Egger M, Smith GD, Altman DG, eds. Systematic Reviews in Health Care: Meta-Analysis in Context, 2nd ed. London: BMJ Publishing Group, 2001; 228–47.
20. Nyaga VN, Arbyn M, Aerts M. Metaprop : a Stata command to perform meta-analysis of binomial data. Arch Public Health 2014; 72: 1–10.
21. Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat 1950; 21: 607–11.
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–88.
23. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557–60.
24. Ott JJ, Stevens GA, Wiersma ST. The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions. BMC Infect Dis 2012; 12: 131.
25. United Nations, Population Division, Department of Economic and Social Affairs. World Population Prospects: The 2015 Revision, 2015. Available at: http://esa.un.org/unpd/wpp/Download/Standard/Fertility/ (accessed 22 January 2016).
26. WHO & UNICEF. WHO-UNICEF estimates of vaccine coverage, 2015. Available at: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragehepb3.html (accessed 22 January 2016).
27. Onakewhor J, Charurat M, Matthew O, Osagie E, Asemota M, Omoigberale A. Immunologic pattern of hepatitis B infection among exposed and non-exposed babies in a PMTCT program in low resource setting: does every exposed newborn require 200 IU of hepatitis B immunoglobulin? J Vaccines Vaccin 2013; 4: 207.
28. Shimakawa Y, Bottomley C, Njie R, Mendy M. The association between maternal hepatitis B e antigen status, as a proxy for perinatal transmission, and the risk of hepatitis B e antigenaemia in Gambian children. BMC Public Health 2014; 14: 532.
29. Yvonnet B, Digoutte P, Denis F, Correa P. [Prevention of mother-to-child transmission of hepatitis B virus by vaccination of the newborn]. Med Afr Noire 1982; 29: 721–31.
30. Marinier E, Barrois V, Larouze B, et al. Lack of perinatal transmission of hepatitis B virus infection in Senegal, West Africa. J Pediatr 1985; 106: 843–9.
31. The Gambia Hepatitis Study Group. Hepatitis B vaccine in the expanded programme of immunisation: the gambian experience. Lancet 1989; 1: 1057–60.
32. Grathwohl J, Ndumbe P, Leke R, Uy A, Gerlich WH, Repp R. [Risk of perinatal hepatitis B virus transmission in mothers with low viral DNA levels detectable by the polymerase chain reaction]. Monatsschr Kinderheilkd 1992; 140: 366–8.
33. Roingeard P, Diouf A, Sankale JL, et al. Perinatal transmission of hepatitis B virus in Senegal, west Africa. Viral Immunol 1993; 6: 65–73.
34. Ekra D, Herbinger KH, Konate S, et al. A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Cote d'Ivoire. Vaccine 2008; 26: 2753–61.
35. Ilboudo D, Simpore J, Ouermi D, et al. Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa. Brazilian J Infect Dis 2010; 14: 219–24.
36. Greenfield C, Osidiana V, Karayiannis P, et al. Perinatal transmission of hepatitis B virus in Kenya: its relation to the presence of serum HBV-DNA and anti-HBe in the mother. J Med Virol 1986; 19: 135–42.
37. Tsega E, Tsega M, Mengesha B, Nordenfelt E, Hansson BG, Lindberg J. Transmission of hepatitis B virus infection in Ethiopia with emphasis on the importance of vertical transmission. Int J Epidemiol 1988; 17: 874–9.
38. Menendez C, Sanchez-Tapias JM, Kahigwa E, et al. Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol 1999; 58: 215–20.
39. Chasela CS, Kourtis AP, Wall P, et al. Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants. J Hepatol 2014; 60: 508–14.
40. Pirillo MF, Scarcella P, Andreotti M, et al. Hepatitis B virus mother-to-child transmission among HIV-infected women receiving lamivudine-containing antiretroviral regimens during pregnancy and breastfeeding. J Viral Hepat 2015; 22: 289–96.
41. Hoffmann CJ, Mashabela F, Cohn S, et al. Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa. J Int AIDS Soc 2014; 17: 18871. eCollection 2014.
42. Edmunds WJ, Medley GF, Nokes DJ, O'Callaghan CJ, Whittle HC, Hall AJ. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect 1996; 117: 313–25.
43. Andersson MI, Maponga TG, Ijaz S, et al. The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa. Vaccine 2013; 31: 5579–84.
44. Ducancelle A, Abgueguen P, Birguel J, et al. High endemicity and low molecular diversity of hepatitis B virus infections in pregnant women in a rural district of North Cameroon. PLoS ONE 2013; 8: 10–2.
45. Wen W-H, Chang M-H, Zhao L-L, et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol 2013; 59: 24–30.
46. Wen WH, Chen HL, Ni YH, et al. Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization. Hepatology 2011; 53: 429–36.
47. Xu D-Z, Yan Y-P, Choi BCK, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002; 67: 20–6.
48. Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst Rev 2006; (2): CD004790.
49. Machaira M, Papaevangelou V, Vouloumanou EK, Tansarli GS, Falagas ME. Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis. J Antimicrob Chemother 2015; 70: 396–404.
50. Chen H-L, Lin L-H, Hu F-C, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology 2012; 142: 773–81. e2.
51. Chen HL, Lee CN, Chang CH, et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology 2015; 62: 375–86.
52. Pan CQ, Duan Z, Dai E, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med 2016; 374: 2324–34.
53. Burk RD, Hwang L-Y, Ho GYF, Shafritz DA, Beasley RP. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994; 170: 1418–23.
54. Lemoine M, Eholié S, Lacombe K. Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach. J Hepatol 2015; 62: 469–76.
55. UNAIDS. Fact Sheet 2015, 2015. Available at: http://www.unaids.org/sites/default/files/media_asset/20150901_FactSheet_2015_en.pdf (accessed 1 April 2016).
56. Shimakawa Y, Toure-Kane C, Mendy M, Thursz M, Lemoine M. Mother-to-child transmission of hepatitis B in sub-Saharan Africa. Lancet Infect Dis 2016; 16: 19–20.